Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

83.3%

5 terminated/withdrawn out of 6 trials

Success Rate

16.7%

-69.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04206917Not ApplicableTerminated

MultiPulse Therapy (MPT) for AF

Role: lead

NCT03093051Not ApplicableTerminated

Unpinning Termination Therapy for VT (US)

Role: lead

NCT05055921Not ApplicableTerminated

MultiPulse Therapy (MPT) for AF (US)

Role: lead

NCT04939584Not ApplicableTerminated

Patient Perception of MultiPulse Therapy™ (MPT™)

Role: lead

NCT02257112Not ApplicableCompleted

Measurement of Low-energy Stimulation in Patients With Atrial Fibrillation

Role: lead

NCT03871231Not ApplicableTerminated

Unpinning Termination Therapy for VT/VF

Role: lead

All 6 trials loaded